Related Experiment Video
Updated: Jul 16, 2026

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
[Present leprosy situation in the world in 2006]
Norihisa Ishii1, Yuzuru Nagaoka, Shuichi Mori
1Department of Bioregulation, Leprosy Research Center, National Institute of Infectious Diseases, 4-2-1 Aoba-cho, Higashimurayama, Tokyo 189-0002, Japan. norishii@nih.go.jp
Leprosy control relies on early detection and multidrug therapy (MDT). Integrating leprosy services into broader healthcare systems is crucial for sustained public health efforts.
Area of Science:
- Epidemiology
- Public Health
- Infectious Disease Control
Context:
- Global leprosy data is reported to the World Health Organization (WHO).
- The Weekly Epidemiological Record disseminates current leprosy statistics.
- Recent reports include data from early 2006.
Purpose:
- To report the global epidemiological situation of leprosy.
- To highlight the ongoing importance of early case detection and multidrug therapy (MDT) in leprosy control.
- To identify challenges in integrating leprosy services into wider healthcare systems.
Summary:
- Leprosy surveillance involves national health divisions reporting data to WHO.
- WHO compiles and publishes this data in the Weekly Epidemiological Record.
- The primary strategy for leprosy control remains early diagnosis and treatment with MDT.
Impact:
- Effective leprosy control requires sustained reporting and data analysis.
- Integrating leprosy care into general health services is essential for long-term management.
- Addressing the challenge of integrated care will improve overall disease management and patient outcomes.
More Related Videos
09:39DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat (VNTR) - Fragment Length Analysis (FLA)
Published on: July 15, 2011
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
Related Concept Videos
Leishmaniasis
Antiprotozoal Agents
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...